Baker Bros. Advisors LP Vor Biopharma Inc. Transaction History

Baker Bros. Advisors LP

  • $9.34 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$4.68 - $6.96 $3.89 Million - $5.79 Million
-832,077 Reduced 56.76%
633,848 $3.41 Million
Q3 2022

Nov 14, 2022
BUY
$3.9 - $5.52 $1.28 Million - $1.81 Million
327,157 Added 28.73%
1,465,925 $5.83 Million
Q2 2022

Aug 15, 2022
BUY
$3.89 - $6.44 $4.43 Million - $7.33 Million
1,138,768 New
1,138,768 $5.66 Million

Others Institutions Holding VOR

# of Institutions
57
Shares Held
41.2M
Call Options Held
9.3K
Put Options Held
100
View Full List

About Vor Biopharma Inc.

VOR Quotes by TradingView
  • Ticker VOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,056,300
  • Market Cap $33.1M
  • Description
  • Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...
More about VOR
Track This Portfolio

Track Baker Bros. Advisors LP Portfolio

Follow Baker Bros. Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Bros. Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email